PTIP associated protein 1, PA1, is an independent prognostic factor for lymphnode negative breast cancer.
Pax transactivation domain interacting protein (PTIP) associated protein 1, PA1, was a newly found protein participating in the modulation of transactivity of nuclear receptor super family members such as estrogen receptor (ER), androgen receptor (AR) and glucocorticoid receptor (GR). Breast cancer...
Main Authors: | Takashi Takeshita, Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, Yoko Omoto, Yumi Honda, Ken-ichi Iyama, Zhenhuan Zhang, Hirotaka Iwase |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24260416/pdf/?tool=EBI |
Similar Items
-
Comparison of ESR1 Mutations in Tumor Tissue and Matched Plasma Samples from Metastatic Breast Cancer Patients
by: Takashi Takeshita, et al.
Published: (2017-10-01) -
Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients
by: Takashi Takeshita, et al.
Published: (2017-11-01) -
Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer
by: Takashi Takeshita, et al.
Published: (2018-02-01) -
An integrative analysis of PIK3CA mutation, PTEN, and INPP4B expression in terms of trastuzumab efficacy in HER2-positive breast cancer.
by: Aiko Sueta, et al.
Published: (2014-01-01) -
The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.
by: Takuya Shiota, et al.
Published: (2016-01-01)